US Chamber Backs Amgen In FTC's $27.8B Merger Challenge
The U.S. Chamber of Commerce is backing biotechnology company Amgen in its bid to complete a $27.8 billion merger with Horizon Therapeutics, saying in an amicus brief Tuesday that if the...To view the full article, register now.
Already a subscriber? Click here to view full article